1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of LPHN2 mRNA CTD PMID:28960355 17beta-estradiol multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of ADGRL2 mRNA CTD PMID:20660070 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO ADGRL2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADGRL2 mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADGRL2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Adgrl2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of ADGRL2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADGRL2 mRNA CTD PMID:25975270 2,4-diaminotoluene decreases expression EXP 6480464 2 and 4-diaminotoluene results in decreased expression of ADGRL2 mRNA CTD PMID:20713471 2,4-dinitrotoluene affects expression ISO Adgrl2 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of ADGRL2 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ADGRL2 mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADGRL2 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of ADGRL2 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of ADGRL2 mRNA CTD PMID:30723492 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of ADGRL2 mRNA CTD PMID:28973697 5-fluorouracil affects response to substance ISO ADGRL2 (Homo sapiens) 6480464 ADGRL2 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil increases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of ADGRL2 mRNA and Propylthiouracil results in increased expression of LPHN2 mRNA CTD PMID:24780913 more ... acetamide decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 acetamide results in decreased expression of ADGRL2 mRNA CTD PMID:31881176 acrylamide increases expression ISO ADGRL2 (Homo sapiens) 6480464 Acrylamide results in increased expression of ADGRL2 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of ADGRL2 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO ADGRL2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of ADGRL2 intron CTD PMID:30157460 aristolochic acid A decreases expression ISO ADGRL2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of ADGRL2 mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO ADGRL2 (Homo sapiens) 6480464 arsenite results in decreased expression of ADGRL2 mRNA CTD PMID:23974009 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ADGRL2 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO ADGRL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of LPHN2 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO ADGRL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of LPHN2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ADGRL2 mRNA CTD PMID:22610609 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of ADGRL2 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions EXP 6480464 AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of ADGRL2 mRNA] CTD PMID:22234961 beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of ADGRL2 mRNA CTD PMID:22234961 bis(2-chloroethyl) sulfide affects expression ISO Adgrl2 (Rattus norvegicus) 6480464 Mustard Gas affects the expression of ADGRL2 mRNA CTD PMID:15651846 bisphenol A increases expression ISO Adgrl2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of ADGRL2 mRNA CTD PMID:12075121 more ... bisphenol A increases methylation ISO ADGRL2 (Homo sapiens) 6480464 bisphenol A results in increased methylation of ADGRL2 gene CTD PMID:31601247 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of ADGRL2 promoter CTD PMID:27312807 bisphenol A increases expression ISO ADGRL2 (Homo sapiens) 6480464 bisphenol A results in increased expression of ADGRL2 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of ADGRL2 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADGRL2 mRNA CTD PMID:28628672 and PMID:31601247 bisphenol A affects expression ISO Adgrl2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of ADGRL2 mRNA CTD PMID:25181051 butanal decreases expression ISO ADGRL2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of ADGRL2 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased expression of ADGRL2 mRNA CTD PMID:33453195 caffeine affects phosphorylation ISO ADGRL2 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of ADGRL2 protein CTD PMID:35688186 calcium atom multiple interactions ISO Adgrl2 (Rattus norvegicus) 6480464 [alpha-latrotoxin binds to ADGRL2 protein] which results in increased uptake of Calcium and [black widow spider venom binds to ADGRL2 protein] which results in increased uptake of Calcium CTD PMID:10026162 calcium(0) multiple interactions ISO Adgrl2 (Rattus norvegicus) 6480464 [alpha-latrotoxin binds to ADGRL2 protein] which results in increased uptake of Calcium and [black widow spider venom binds to ADGRL2 protein] which results in increased uptake of Calcium CTD PMID:10026162 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADGRL2 gene and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of ADGRL2 CTD PMID:20938992 chromium atom decreases expression ISO ADGRL2 (Homo sapiens) 6480464 Chromium results in decreased expression of ADGRL2 mRNA CTD PMID:21437242 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRL2 mRNA CTD PMID:15467011 copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRL2 mRNA CTD PMID:15467011 Cuprizon decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of ADGRL2 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO ADGRL2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ADGRL2 mRNA CTD PMID:20106945 and PMID:25562108 dexamethasone decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of ADGRL2 mRNA CTD PMID:14618091 dexamethasone multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADGRL2 mRNA CTD PMID:28628672 dibutyl phthalate increases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of ADGRL2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ADGRL2 mRNA CTD PMID:17361019 and PMID:21266533 dorsomorphin multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRL2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO ADGRL2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ADGRL2 mRNA CTD PMID:29803840 endosulfan decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of ADGRL2 mRNA CTD PMID:29391264 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of ADGRL2 mRNA CTD PMID:35436446 ethanol increases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Ethanol results in increased expression of ADGRL2 mRNA CTD PMID:15353170 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ADGRL2 mRNA CTD PMID:30319688 flusilazole affects expression EXP 6480464 flusilazole affects the expression of ADGRL2 mRNA CTD PMID:21195148 flutamide decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of ADGRL2 mRNA CTD PMID:24136188 and PMID:24793618 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADGRL2 gene and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of ADGRL2 CTD PMID:20938992 fonofos increases methylation ISO ADGRL2 (Homo sapiens) 6480464 Fonofos results in increased methylation of ADGRL2 promoter CTD PMID:22847954 FR900359 affects phosphorylation ISO ADGRL2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of ADGRL2 protein CTD PMID:37730182 fulvestrant multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of ADGRL2 gene CTD PMID:31601247 fulvestrant decreases methylation ISO ADGRL2 (Homo sapiens) 6480464 Fulvestrant results in decreased methylation of ADGRL2 gene CTD PMID:31601247 furan increases methylation ISO Adgrl2 (Rattus norvegicus) 6480464 furan results in increased methylation of ADGRL2 gene CTD PMID:22079235 gentamycin increases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of ADGRL2 mRNA CTD PMID:33387578 hexaconazole affects expression EXP 6480464 hexaconazole affects the expression of ADGRL2 mRNA CTD PMID:21195148 indometacin multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADGRL2 mRNA CTD PMID:28628672 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADGRL2 gene and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of ADGRL2 CTD PMID:20938992 Licochalcone B decreases expression ISO ADGRL2 (Homo sapiens) 6480464 licochalcone B results in decreased expression of ADGRL2 mRNA CTD PMID:33647349 methapyrilene decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of ADGRL2 mRNA CTD PMID:30467583 methotrexate affects response to substance ISO ADGRL2 (Homo sapiens) 6480464 ADGRL2 protein affects the susceptibility to Methotrexate CTD PMID:16217747 nefazodone decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 nefazodone results in decreased expression of ADGRL2 mRNA CTD PMID:24136188 nimesulide decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 nimesulide results in decreased expression of ADGRL2 mRNA CTD PMID:24136188 nitrofen decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 nitrofen results in decreased expression of ADGRL2 mRNA CTD PMID:33484710 oxaliplatin multiple interactions ISO Adgrl2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ADGRL2 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ADGRL2 mRNA CTD PMID:34911549 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ADGRL2 mRNA CTD PMID:17562736 paracetamol increases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of ADGRL2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO ADGRL2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ADGRL2 mRNA CTD PMID:21420995 parathion increases methylation ISO ADGRL2 (Homo sapiens) 6480464 Parathion results in increased methylation of ADGRL2 promoter CTD PMID:22847954 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADGRL2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 pirinixic acid results in decreased expression of ADGRL2 mRNA CTD PMID:19162173 potassium chromate decreases expression ISO ADGRL2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of ADGRL2 mRNA CTD PMID:22714537 progesterone multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of ADGRL2 mRNA CTD PMID:20660070 quercetin decreases expression ISO ADGRL2 (Homo sapiens) 6480464 Quercetin results in decreased expression of ADGRL2 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADGRL2 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRL2 mRNA CTD PMID:27188386 sunitinib increases expression ISO ADGRL2 (Homo sapiens) 6480464 Sunitinib results in increased expression of ADGRL2 mRNA CTD PMID:31533062 temozolomide decreases expression ISO ADGRL2 (Homo sapiens) 6480464 Temozolomide results in decreased expression of ADGRL2 mRNA CTD PMID:31758290 terbufos increases methylation ISO ADGRL2 (Homo sapiens) 6480464 terbufos results in increased methylation of ADGRL2 promoter CTD PMID:22847954 tetrachloromethane increases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of ADGRL2 mRNA CTD PMID:33387578 titanium dioxide decreases expression ISO Adgrl2 (Rattus norvegicus) 6480464 titanium dioxide results in decreased expression of ADGRL2 mRNA CTD PMID:30012374 topotecan multiple interactions ISO Adgrl2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ADGRL2 mRNA CTD PMID:25729387 topotecan increases expression ISO Adgrl2 (Rattus norvegicus) 6480464 Topotecan results in increased expression of ADGRL2 mRNA CTD PMID:25729387 triadimefon affects expression EXP 6480464 triadimefon affects the expression of ADGRL2 mRNA CTD PMID:21195148 triptonide affects expression EXP 6480464 triptonide affects the expression of ADGRL2 mRNA CTD PMID:33045310 valproic acid increases expression ISO ADGRL2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ADGRL2 mRNA CTD PMID:24383497 more ... valproic acid multiple interactions ISO ADGRL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRL2 mRNA CTD PMID:27188386 vinclozolin increases methylation ISO Adgrl2 (Rattus norvegicus) 6480464 vinclozolin results in increased methylation of ADGRL2 gene CTD PMID:31682807 vorinostat increases expression ISO ADGRL2 (Homo sapiens) 6480464 vorinostat results in increased expression of ADGRL2 mRNA CTD PMID:27188386
